NGM Biopharmaceuticals Updates IPO Filing – Will Raise Over $122 Million

NGM Updated its IPO filing to include an estimated price range of $14 to $16 per share. If all available shares are purchased, the IPO will raise more than $122 Million. The company intends to trade under the symbol, “NGM.”